|Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)|
VO Puntmann, ML Carerj, I Wieters, M Fahim, C Arendt, J Hoffmann, ...
JAMA cardiology 5 (11), 1265-1273, 2020
|Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis|
M Haase, R Bellomo, P Devarajan, P Schlattmann, A Haase-Fielitz
Am J Kidney Dis 54 (6), 1012-1024, 2009
|Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy|
VO Puntmann, T Voigt, Z Chen, M Mayr, R Karim, K Rhode, A Pastor, ...
JACC: Cardiovascular Imaging 6 (4), 475-484, 2013
|T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure|
VO Puntmann, G Carr-White, A Jabbour, CY Yu, R Gebker, S Kelle, ...
JACC: Cardiovascular Imaging 9 (1), 40-50, 2016
|Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease|
New England Journal of Medicine 380 (25), 2418-2428, 2019
|Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study|
D Dabir, N Child, A Kalra, T Rogers, R Gebker, A Jabbour, S Plein, CY Yu, ...
Journal of Cardiovascular Magnetic Resonance 16 (1), 1-12, 2014
|T1 mapping in characterizing myocardial disease: a comprehensive review|
VO Puntmann, E Peker, Y Chandrashekhar, E Nagel
Circulation research 119 (2), 277-299, 2016
|2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 …|
Writing Committee, TJ Gluckman, NM Bhave, LA Allen, EH Chung, ...
Journal of the American College of Cardiology 79 (17), 1717-1756, 2022
|Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass|
SM Tuladhar, VO Püntmann, M Soni, PP Punjabi, RG Bogle
Journal of cardiovascular pharmacology 53 (3), 261-266, 2009
|T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international T1 multicenter …|
R Hinojar, N Varma, N Child, B Goodman, A Jabbour, CY Yu, R Gebker, ...
Circulation: Cardiovascular Imaging 8 (12), e003285, 2015
|Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury|
J Barallobre-Barreiro, A Didangelos, FA Schoendube, I Drozdov, X Yin, ...
Circulation 125 (6), 789-802, 2012
|Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus|
VO Puntmann, D D’Cruz, Z Smith, A Pastor, P Choong, T Voigt, ...
Circulation: Cardiovascular Imaging 6 (2), 295-301, 2013
|Native T1 in Discrimination of Acute and Convalescent Stages in Patients With Clinical Diagnosis of Myocarditis: A Proposed Diagnostic Algorithm Using CMR|
R Hinojar, L Foote, EA Ucar, T Jackson, A Jabbour, CY Yu, J McCrohon, ...
JACC: Cardiovascular Imaging, 2014
|How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease|
Postgraduate medical journal 85 (1008), 538-545, 2009
|Standardization of T1 measurements with MOLLI in differentiation between health and disease–the ConSept study|
T Rogers, D Dabir, I Mahmoud, T Voigt, T Schaeffter, E Nagel, ...
Journal of Cardiovascular Magnetic Resonance 15 (1), 1-9, 2013
|T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis|
VO Puntmann, A Isted, R Hinojar, L Foote, G Carr-White, E Nagel
Radiology 285 (1), 63-72, 2017
|Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use|
SI Mavrogeni, GD Kitas, T Dimitroulas, PP Sfikakis, P Seo, S Gabriel, ...
International journal of cardiology 217, 135-148, 2016
|Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I-analytical validation and clinical qualification|
VO Puntmann, S Valbuena, R Hinojar, SE Petersen, JP Greenwood, ...
Journal of Cardiovascular Magnetic Resonance 20, 1-23, 2018
|Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment?|
MJ Thomson, V Puntmann, JC Kaski
Cardiovascular Drugs and Therapy 21, 195-210, 2007
|Native T1 and ECV of noninfarcted myocardium and outcome in patients with coronary artery disease|
VO Puntmann, G Carr-White, A Jabbour, CY Yu, R Gebker, S Kelle, A Rolf, ...
Journal of the American College of Cardiology 71 (7), 766-778, 2018